James Louis Gillilland, DO | |
1131 N York Cir, Mesa, AZ 85213-5328 | |
(480) 964-4190 | |
Not Available |
Full Name | James Louis Gillilland |
---|---|
Gender | Male |
Speciality | Allergy & Immunology - Allergy |
Location | 1131 N York Cir, Mesa, Arizona |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326008707 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | 01610 (Iowa) | Secondary |
207KA0200X | Allergy & Immunology - Allergy | 005365 (Arizona) | Primary |
Mailing Address | Practice Location Address |
---|---|
James Louis Gillilland, DO 1131 N York Cir, Mesa, AZ 85213-5328 Ph: (480) 964-4190 | James Louis Gillilland, DO 1131 N York Cir, Mesa, AZ 85213-5328 Ph: (480) 964-4190 |
News Archive
A new study, published in PeerJ, shows how University of Liverpool researchers have used a newly developed eye movement test to improve the understanding of how parts of the brain work.
Men largely make decisions about prostate cancer screening based on conversations with their clinicians, but these discussions often do not include information about the risks of testing in addition to the benefits, according to a report in the September 28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
A revolutionary daily oral vitamin spray by health pioneers BetterYou can boost vitamin D levels in deficient children, particularly common in those with epilepsy.
MRO Corp., a leading provider of disclosure management applications and services for healthcare organizations, today announced that it has acquired the assets of Keystone Management Solutions, a provider of release of information services based in Malvern, Pennsylvania. This acquisition will enable MRO to continue building its market presence across Pennsylvania, Massachusetts and Louisiana, where Keystone Management Solutions currently serves hospitals and health systems.
Researchers in Sweden and China have presented a new methodology for predicting mutation "hotspot" sites within severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.
› Verified 7 days ago